Business
Significant Milestone - Completion of IRX211 Phase 1 Trial
Significant Milestone - Completion of IRX211 Phase 1 Trial
About this update from Nexalis Therapeutics Limited
[{"type":"text","content":"Nexalis Therapeutics Limited has released a press release. View Attachment","length":249,"tagName":"div"}]